PO.MCB09.03 · 分子与细胞生物学
急性睡眠剥夺重塑与癌症风险相关的代谢和线粒体通路
Acute sleep deprivation reprograms metabolic and mitochondrial pathways linked to cancer risk
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
睡眠剥夺很常见,且已被证实与癌症风险升高相关,然而将急性睡眠丧失与癌症联系起来的即时哺乳动物应答仍不清楚。我们探讨了在小鼠模型中,单次5小时的急性睡眠剥夺(ASD)是否会重塑调控全身能量代谢的各器官的代谢和线粒体通路。12周龄C57BL/6雌性小鼠接受ASD或自由睡眠处理;随后立即采集肝脏、海马、前额叶皮层和腓肠肌,并通过RT-qPCR对能量感应(AMPK)、葡萄糖转运(GLUT3)、线粒体动力学(DRP1/MFN1/OPA1)以及肝脏脂质/胆固醇处理(ABCA1/SCARB1/载脂蛋白)进行谱分析。ASD引发了快速的、组织选择性的重塑:脑区中AMPK/GLUT3和线粒体动力学相关转录本升高,而肝脏胆固醇转运和载脂蛋白发生改变;然而骨骼肌几乎无变化。这些协调一致的改变对应于癌症相关过程——细胞能量代谢失调、线粒体质量控制/氧化还原,以及塑造膜信号传导和组织炎症的固醇通量,从而将睡眠状态定位为一个可调节的、全系统性的癌症易感性和进展决定因素。正在进行的研究将探讨反复ASD或睡眠恢复是否会调节这些通路以及相关的肿瘤相关终点。
查看英文原文 English abstract
Sleep deprivation is common and has been linked to elevated cancer risk, yet the immediate mammalian responses that connect acute sleep loss to cancer remain unclear. We asked whether a single 5-hour bout of acute sleep deprivation (ASD) reprograms metabolic and mitochondrial pathways across organs that govern whole-body energetics in a mouse model. Twelve-week C57BL/6 female mice underwent ASD or ad lib sleep; liver, hippocampus, prefrontal cortex, and gastrocnemius were collected immediately and profiled by RT-qPCR for energy sensing (AMPK), glucose transport (GLUT3), mitochondrial dynamics (DRP1/MFN1/OPA1), and hepatic lipid/cholesterol handling (ABCA1/SCARB1/apolipoproteins). ASD triggered rapid, tissue-selective remodeling: AMPK/GLUT3 and mitochondrial-dynamics transcripts rose in brain regions, while hepatic cholesterol transport and apolipoproteins were altered; however skeletal muscle showed minimal change. These coordinated shifts map to cancer-relevant processes-deregulated cellular energetics, mitochondrial quality control/redox, and sterol flux that shapes membrane signaling and tissue inflammation, positioning sleep state as a modifiable, system-wide determinant of cancer susceptibility and progression. Ongoing work will examine whether repeated ASD or sleep restoration tunes these pathways and related tumor-relevant endpoints.
利益披露 Disclosure
B. Varamini, None..
H. Kim, None..
P. Kim, None..
M. Lange, None..
S. Zeng, None..
J. Tudor, None.